Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia
Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia: a Prospective Randomized Clinical Trial
Sponsor: ZhiYong Peng
Terminated
the study was started in the second half of the outbreak, and the number of qualifying COVID-19 patients decreased with the control of the epidemic so that we had to stop our trial before reaching the predefined sample size.
Other Pneumonia, Ventilator-Associated trials with similar outcome
This PHASE2 trial investigates Pneumonia, Ventilator-Associated and Pneumonia, Viral and is currently terminated or withdrawn. ZhiYong Peng leads this study, which shows 7 recorded versions since 2020 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Dec 2021 — Jul 2024 [monthly]
Terminated PHASE2
-
Jan 2021 — Dec 2021 [monthly]
Terminated PHASE2
-
Nov 2020 — Jan 2021 [monthly]
Terminated PHASE2
Status: Recruiting → Terminated
▶ Show 2 earlier versions
-
Apr 2020 — Nov 2020 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
Mar 2020 — Apr 2020 [monthly]
Not Yet Recruiting PHASE2
First recorded
Feb 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- ZhiYong Peng
For direct contact, visit the study record on ClinicalTrials.gov .